Maffucci syndrome: a rare and important differential diagnosis for lumpy hands.

Hand Surg

Department of Plastic and Reconstructive Surgery, University of Sydney, Royal North Shore Hospital, Sydney, Australia.

Published: October 2007

Maffucci syndrome belongs to a group of disorders known as enchondromatoses. First described in 1881, it features multiple enchondromas and vascular abnormalities, mainly haemangiomas. The syndrome is a variant of Ollier's disease, which consists solely of multiple enchondromas. This case serves to highlight important features of a rare condition.

Download full-text PDF

Source
http://dx.doi.org/10.1142/S0218810407003365DOI Listing

Publication Analysis

Top Keywords

maffucci syndrome
8
multiple enchondromas
8
syndrome rare
4
rare differential
4
differential diagnosis
4
diagnosis lumpy
4
lumpy hands
4
hands maffucci
4
syndrome belongs
4
belongs group
4

Similar Publications

How do lesions affect limb lengthening in children with Ollier's disease?

BMC Musculoskelet Disord

January 2025

Department of Pediatric Orthopaedics, Children's Hospital of Fudan University, National Children's Medical Center, 399 Wanyuan Rd, Minhang District, Shanghai, 201102, China.

Purpose: Ollier's disease (multiple enchondromatosis) can cause severe lower limb length discrepancy and deformity in children. Osteotomy and limb lengthening with external fixation can correct the lower extremity deformity. There may be lesions in the osteotomy part (OP), and the internal fixation part of the external fixation(FP).

View Article and Find Full Text PDF

Blue rubber blister nevus syndrome: A case report.

World J Gastrointest Surg

November 2024

Department of Critical Care Medicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou 450003, Henan Province, China.

Background: Blue rubber blister nevus syndrome (BRBNS) is a congenital, rare disease characterized by venous malformations of the skin and internal organs, affecting all systems throughout the body. The pathogenesis is unknown. There is no consensus on the treatment of BRBNS.

View Article and Find Full Text PDF

The management of children with syndromes associated with an increased risk of benign and malignant neoplasms is a complex challenge for healthcare professionals. The 2023 AACR Childhood Cancer Predisposition Workshop provided updated consensus guidelines on cancer surveillance in these syndromes, aiming to improve early detection, intervention, and reduce morbidity associated with such neoplasms. In this paper, we review several of the rare conditions discussed in this workshop.

View Article and Find Full Text PDF

Spectrum of IDH-mutant tumors in Ollier-Maffucci disease: the triple interaction theory.

Orphanet J Rare Dis

November 2024

Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neuro-oncologie, Paris, France.

Article Synopsis
  • The study aims to enhance understanding of tumor development in patients with Ollier disease (OD) and Maffucci syndrome (MS), focusing on IDH-mutated tumors and their origins.
  • It proposes that a single IDH-mutant cell could lead to various tumors due to early embryonic mutations and that not all mutated cells will display the IDH mutant characteristics.
  • Additionally, it suggests that specific genetic predispositions (SNPs) may increase the likelihood of developing particular tumors in these patients, linking developmental defects to tumor occurrence.
View Article and Find Full Text PDF

Enchondromas are a common tumor in bone that can occur as multiple lesions in enchondromatosis, which is associated with deformity of the affected bone. These lesions harbor somatic mutations in IDH and driving expression of a mutant Idh1 in Col2 expressing cells in mice causes an enchondromatosis phenotype. Here we compared growth plates from E18.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!